For Tenet Healthcare, the consensus EPS estimate for the current year has increased 24.5% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy). Looking more specifically, Arcutis Biotherapeutics, Inc. belongs to the Medical - Biomedical and Genetics industry, a group that includes 489 individual stocks and currently sits at #147 in the Zacks Industry Rank. Stocks in this group have lost about 0.4% so far this year, so ARQT is performing better this group in terms of year-to-date ...

HCA Healthcare (HCA) came out with quarterly earnings of $6.84 per share, beating the Zacks Consensus Estimate of $6.19 per share. This compares to earnings of $5.5 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +10.50%. A quarter ago, it was expected that this hospital operator would post earnings of $5.77 per share when it actually produced earnings of $6.45, delivering a surprise of +11.79%.Over the last four quarters, the ...

Core Viewpoint - Tenet Healthcare (THC) has seen a 15.2% increase in shares over the past month, outperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Estimates Movement - Estimates for Tenet Healthcare have trended upward in the past month, with a consensus estimate shift of 5.78% [2] VGM Scores - Tenet has a Growth Score of B, a Momentum Score of F, and a Value Score of A, placing it in the top 20% for the value investment strategy, resulting in an aggregate VGM Score of A [3] Outlook - The upward trend in estimates and the magnitude of revisions suggest a positive outlook for Tenet, reflected in a Zacks Rank 2 (Buy), indicating expectations for above-average returns in the coming months [4] Industry Performance - Tenet operates within the Zacks Medical - Hospital industry, where Universal Health Services (UHS) has gained 7.5% over the past month, reporting revenues of $4.1 billion with a year-over-year change of +6.7% and an EPS of $4.84 compared to $3.70 a year ago [5] Earnings Expectations for Industry Player - Universal Health Services is projected to post earnings of $4.89 per share for the current quarter, reflecting a year-over-year change of +13.5%, with a Zacks Consensus Estimate change of +1% over the last 30 days, resulting in a Zacks Rank 3 (Hold) [6]

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...

Group 1 - Acadia Healthcare Company, Inc. (ACHC) is experiencing significant attention from investors due to high implied volatility in its options market, particularly the Jun 20, 2025 $65 Call option [1] - Implied volatility indicates the market's expectation of future price movement, suggesting that investors anticipate a substantial price change or an upcoming event that could trigger a rally or sell-off [2] - Acadia Healthcare currently holds a Zacks Rank 3 (Hold) in the Medical - Hospital industry, which is in the top 35% of the Zacks Industry Rank, but analysts have not increased earnings estimates for the current quarter, with a consensus estimate dropping from 77 cents to 71 cents per share [3] Group 2 - The high implied volatility surrounding Acadia Healthcare may indicate a developing trading opportunity, as options traders often seek to sell premium on options with high implied volatility to capture decay [4]

Core Viewpoint - Acadia Healthcare reported quarterly earnings of $0.40 per share, exceeding the Zacks Consensus Estimate of $0.35 per share, but down from $0.84 per share a year ago [1][2] Financial Performance - The company achieved revenues of $770.51 million for the quarter ended March 2025, aligning with the Zacks Consensus Estimate and showing a slight increase from $768.05 million year-over-year [3] - Acadia Healthcare has surpassed consensus EPS estimates three times over the last four quarters, but has only topped revenue estimates once in the same period [2][3] Stock Performance - The stock has declined approximately 39.9% since the beginning of the year, contrasting with the S&P 500's decline of 3.8% [4] - The current Zacks Rank for Acadia Healthcare is 4 (Sell), indicating expectations of underperformance in the near future [7] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $0.77 on revenues of $852.98 million, and for the current fiscal year, it is $2.68 on revenues of $3.33 billion [8] - The trend of estimate revisions for Acadia Healthcare has been unfavorable leading up to the earnings release [7] Industry Context - The Medical - Hospital industry, to which Acadia Healthcare belongs, is currently ranked in the top 40% of over 250 Zacks industries, suggesting a favorable environment compared to the bottom 50% [9]

Tenet Healthcare (THC) came out with quarterly earnings of $4.36 per share, beating the Zacks Consensus Estimate of $3.11 per share. This compares to earnings of $3.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 40.19%. A quarter ago, it was expected that this hospital operator would post earnings of $2.93 per share when it actually produced earnings of $3.44, delivering a surprise of 17.41%.Over the last four quarters, th ...

Core Insights - Universal Health Services (UHS) reported quarterly earnings of $4.84 per share, exceeding the Zacks Consensus Estimate of $4.36 per share, and up from $3.70 per share a year ago, representing an earnings surprise of 11.01% [1] - The company posted revenues of $4.1 billion for the quarter ended March 2025, which was 1.06% below the Zacks Consensus Estimate, but an increase from $3.84 billion year-over-year [2] - UHS has surpassed consensus EPS estimates three times over the last four quarters and has topped consensus revenue estimates three times as well [2] Earnings Outlook - The sustainability of UHS's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $4.84 on revenues of $4.21 billion, and for the current fiscal year, it is $18.94 on revenues of $17.12 billion [7] Industry Context - The Medical - Hospital industry, to which UHS belongs, is currently ranked in the top 11% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5][6]